B. Riley Issues Optimistic Forecast for Joint Earnings

The Joint Corp. (NASDAQ:JYNT - Free Report) - Equities research analysts at B. Riley raised their Q4 2025 earnings estimates for shares of Joint in a report issued on Friday, August 8th. B. Riley analyst J. Van. Sinderen now anticipates that the company will post earnings per share of $0.16 for the quarter, up from their prior estimate of $0.11. B. Riley currently has a "Buy" rating and a $18.00 price target on the stock. The consensus estimate for Joint's current full-year earnings is $0.11 per share. B. Riley also issued estimates for Joint's FY2026 earnings at $0.52 EPS and FY2027 earnings at $0.68 EPS.

Joint (NASDAQ:JYNT - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The firm had revenue of $13.27 million during the quarter, compared to analysts' expectations of $13.32 million. Joint had a negative net margin of 7.02% and a positive return on equity of 0.67%.

Separately, Lake Street Capital decreased their price target on shares of Joint from $20.00 to $16.00 and set a "buy" rating for the company in a research report on Friday, May 9th.

Joint Stock Up 2.6%

JYNT stock traded up $0.28 during midday trading on Monday, hitting $11.08. The company's stock had a trading volume of 48,519 shares, compared to its average volume of 46,006. Joint has a 52-week low of $9.58 and a 52-week high of $13.47. The firm has a market capitalization of $169.56 million, a P/E ratio of -33.58 and a beta of 1.53. The firm has a 50-day simple moving average of $11.50 and a 200-day simple moving average of $11.10.

Hedge Funds Weigh In On Joint

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets raised its holdings in shares of Joint by 6.8% in the 4th quarter. BNP Paribas Financial Markets now owns 24,031 shares of the company's stock valued at $255,000 after purchasing an additional 1,521 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Joint by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 293,133 shares of the company's stock valued at $3,116,000 after purchasing an additional 1,552 shares in the last quarter. Wells Fargo & Company MN raised its holdings in shares of Joint by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 5,088 shares of the company's stock valued at $54,000 after purchasing an additional 1,735 shares in the last quarter. Barclays PLC raised its holdings in shares of Joint by 6.9% in the 4th quarter. Barclays PLC now owns 27,380 shares of the company's stock valued at $291,000 after purchasing an additional 1,771 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in shares of Joint by 32.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company's stock valued at $86,000 after purchasing an additional 1,810 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company's stock.

Joint announced that its Board of Directors has authorized a share buyback plan on Thursday, June 5th that permits the company to repurchase $5.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 2.7% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its shares are undervalued.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.